Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates

Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.